ArticleChemistry & biodiversity2026
Synthesis, Characterization, and Inhibitory Potential of Fagonia arabica L. Phytochemicals Coated Gold Nanoparticles Against Drug-Resistant Mycobacterium tuberculosis.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In the current study, a novel formulation comprising gold Nanoparticles (AuNPs) and Fagonia arabica L. (F. arabica L.) phytochemicals, was designed and conjugated to evaluate inhibitory potential against Mycobacterium tuberculosis (Mtb). The chemically synthesized AuNPs were characterized followed by anti-Mtb potential of F. arabica L. extracts were which is significantly increased when used as a conjugate with AuNPs. The drug-resistant Mtb isolates in MGIT show that F. arabica L. phytochemicals, in conjugation with AuNPs, exhibit greater inhibitory activity than plant extracts alone at a concentration of 4.28 µg/mL. In vivo analysis showed no significant toxicity of the nanoconjugates. The plant extract was analyzed using ultra-high performance liquid chromatography in which 17 antimycobacterial components, including 14 from Traditional Chinese Medicine Class, were also identified. While plant-mediated AuNPs synthesis and their general antibacterial properties have been reported, our study offers distinct novelty through the specific use of F. arabica L., direct comparison of chemical versus green synthesis, the efficacy against MDR clinical isolates, and combined in vitro efficacy and in vivo safety validation. Overall, a good anti-TB activity of F. arabica L. in conjugation with AuNPs was found, paving the way for the development of new anti-TB agents against drug-resistant Mtb.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.